Olopatadine Hydrochloride
- Product NDC
- 61314-272
- 11-digit product format
- 613140272
- Labeler code
- 61314
- Product ID
- 61314-272_87463617-ff29-4f2b-9b8c-72c36bb099ba
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olopatadine Hydrochloride
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Sandoz Inc
- Application
- NDA021545
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2007-02-15
- Marketing end
- 2022-09-30
- Substance
- OLOPATADINE HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61314-272-25 | 61314027225 | 1 BOTTLE, DROPPER in 1 CARTON (61314-272-25) > 2.5 mL in 1 BOTTLE, DROPPER | 2017-06-09 | 2022-09-30 | No | No | Current |